Medroxyprogesterone Acetate

Endometrial Hyperplasia, Endometriosis, Chronic Pain + 18 more
Treatment
7 FDA approvals
20 Active Studies for Medroxyprogesterone Acetate

What is Medroxyprogesterone Acetate

Medroxyprogesterone acetateThe Generic name of this drug
Treatment SummaryMedroxyprogesterone acetate (MPA) is a hormone-based medication that has an improved resistance to being broken down in the body. It is used to treat various conditions, such as abnormal menstrual bleeding, menopause symptoms, endometrial hyperplasia, endometriosis pain, and prevent pregnancy. It is also used to treat cancer and osteoporosis. MPA was approved by the FDA in 1959.
Medroxyprogesterone Acetateis the brand name
image of different drug pills on a surface
Medroxyprogesterone Acetate Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Medroxyprogesterone Acetate
Medroxyprogesterone acetate
1959
139

Approved as Treatment by the FDA

Medroxyprogesterone acetate, also known as Medroxyprogesterone Acetate, is approved by the FDA for 7 uses such as Vulvo Vaginal Atrophy and Postmenopausal Osteoporosis .
Vulvo Vaginal Atrophy
Used to treat Vulvo Vaginal Atrophy in combination with Conjugated estrogens
Postmenopausal Osteoporosis
Used to treat Postmenopausal Osteoporosis in combination with Conjugated estrogens
Vasomotor Symptoms Associated With Menopause
Used to treat Vasomotor Symptoms Associated With Menopause in combination with Conjugated estrogens
Hot flashes
Used to treat Menopause in combination with Conjugated estrogens
Hot Flashes
Used to treat Vasomotor Symptoms Associated With Menopause in combination with Conjugated estrogens
Osteoporosis, Postmenopausal
Used to treat Postmenopausal Osteoporosis in combination with Conjugated estrogens
Atrophic
Used to treat Vulvo Vaginal Atrophy in combination with Conjugated estrogens

Effectiveness

How Medroxyprogesterone Acetate Affects PatientsMedroxyprogesterone acetate (MPA) works by stopping the production of certain hormones and reducing the presence of estrogen in the body. Depending on the form, it can last a long time in the body, from one day to several weeks. Doses of MPA range from 5mg taken orally daily to 1000mg as a weekly shot. Unfortunately, long-term use of MPA has been linked to reduced bone density, especially in adolescents, which can lead to increased risk of osteoporosis and fractures later in life.
How Medroxyprogesterone Acetate works in the bodyMedroxyprogesterone acetate (MPA) stops ovulation and thins the endometrium, making it an effective form of contraception. It also affects the endometrium by reducing the number of estrogen receptors and the amount of DNA it produces. MPA can also cause certain cancer cells to die and blocks GABA-A receptors.

When to interrupt dosage

The recommended dosage of Medroxyprogesterone Acetate is contingent upon the discerned condition, including Hormonal Contraception, Amenorrhea and Postmenopausal Osteoporosis. The amount of dosage is dependent on the administration technique (e.g. Tablet - Oral or Intramuscular) provided in the table below.
Condition
Dosage
Administration
Endometriosis
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Chronic Pain
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Amenorrhea
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Osteoporosis
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
conjugated estrogen
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
hypoestrogenism
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Birth Control
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Endometriosis
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Endometrial Neoplasms
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Fracture
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Hot flashes
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Osteoporosis, Postmenopausal
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Estrogen Replacement Therapy
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Hot Flashes
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Uterine hemorrhage
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Atrophic
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Hormonal Contraception
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Kidney Neoplasms
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Pharmaceutical Preparations
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral
Pharmaceutical Preparations
, 2.5 mg, 10.0 mg, 5.0 mg, 150.0 mg/mL, 400.0 mg/mL, 1.5 mg, 100.0 mg, 1040.0 mg/mL, 500.0 mg, 250.0 mg, 200.0 mg, 400.0 mg, 250.0 mg/mL, 50.0 mg/mL
, Oral, Tablet, Tablet - Oral, Intramuscular, Injection, suspension - Intramuscular, Injection, suspension, Tablet, sugar coated, Tablet, sugar coated - Oral, Suspension, Suspension - Intramuscular, Kit; Tablet, Kit; Tablet - Oral, Subcutaneous, Injection, suspension - Subcutaneous, Kit, Injection, suspension, extended release, Injection, suspension, extended release - Intramuscular, Injection, Injection - Intramuscular, Kit - Oral

Warnings

Medroxyprogesterone Acetate Contraindications
Condition
Risk Level
Notes
Thromboembolism
Do Not Combine
Breast
Do Not Combine
Thrombophlebitis
Do Not Combine
Neoplasms, Hormone-Dependent
Do Not Combine
Breast
Do Not Combine
Breast Cancer
Do Not Combine
Stroke
Do Not Combine
Vascular Diseases
Do Not Combine
Thromboembolism
Do Not Combine
Liver Disease
Do Not Combine
estrogen-dependent neoplasia
Do Not Combine
suspected pregnancy
Do Not Combine
Disease
Do Not Combine
undiagnosed abnormal genital bleeding
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Medroxyprogesterone Acetate may interact with Pulse Frequency
There are 20 known major drug interactions with Medroxyprogesterone Acetate.
Common Medroxyprogesterone Acetate Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Medroxyprogesterone acetate.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be increased when combined with Medroxyprogesterone acetate.
Alectinib
Major
The metabolism of Alectinib can be increased when combined with Medroxyprogesterone acetate.
Alpelisib
Major
The metabolism of Alpelisib can be increased when combined with Medroxyprogesterone acetate.
Aminophylline
Major
The metabolism of Aminophylline can be increased when combined with Medroxyprogesterone acetate.
Medroxyprogesterone Acetate Toxicity & Overdose RiskThe lowest toxic dose of medroxyprogesterone acetate in rats has been found to be greater than 6400mg/kg and greater than 16g/kg in mice. Overdosing on MPA may cause nausea, vomiting, breast tenderness, dizziness, abdominal pain, drowsiness, fatigue, and menstrual bleeding. If a patient receives too much of a MPA injection, they should seek medical help immediately. Treatment involves stopping the MPA and providing symptomatic care.
image of a doctor in a lab doing drug, clinical research

Medroxyprogesterone Acetate Novel Uses: Which Conditions Have a Clinical Trial Featuring Medroxyprogesterone Acetate?

406 active clinical trials are presently assessing the potential of Medroxyprogesterone Acetate for the management of Osteoporosis, Amenorrhea and Hormonal Contraception.
Condition
Clinical Trials
Trial Phases
Endometriosis
29 Actively Recruiting
Early Phase 1, Phase 2, Phase 3, Not Applicable, Phase 4
Osteoporosis
34 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3
Chronic Pain
143 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Phase 4, Phase 3, Early Phase 1
Endometrial Neoplasms
0 Actively Recruiting
Fracture
0 Actively Recruiting
Osteoporosis, Postmenopausal
0 Actively Recruiting
Pharmaceutical Preparations
0 Actively Recruiting
Birth Control
24 Actively Recruiting
Not Applicable, Phase 3, Phase 4, Early Phase 1
Estrogen Replacement Therapy
0 Actively Recruiting
Hormonal Contraception
0 Actively Recruiting
Endometriosis
3 Actively Recruiting
Phase 4, Not Applicable
Hot Flashes
1 Actively Recruiting
Not Applicable
Kidney Neoplasms
37 Actively Recruiting
Phase 3, Phase 1, Phase 2, Not Applicable
conjugated estrogen
0 Actively Recruiting
Hot flashes
17 Actively Recruiting
Phase 1, Phase 4, Not Applicable, Early Phase 1, Phase 2, Phase 3
hypoestrogenism
2 Actively Recruiting
Phase 4
Atrophic
3 Actively Recruiting
Phase 4, Not Applicable
Amenorrhea
0 Actively Recruiting
Pharmaceutical Preparations
0 Actively Recruiting
Endometrial Hyperplasia
4 Actively Recruiting
Not Applicable, Phase 2, Phase 3

Medroxyprogesterone Acetate Reviews: What are patients saying about Medroxyprogesterone Acetate?

5Patient Review
10/11/2019
Medroxyprogesterone Acetate for Abnormal Uterine Bleeding caused by Imbalance of Hormones
This medication has helped me to regulate my periods. The only downside is that it makes me feel drowsy.
5Patient Review
10/21/2020
Medroxyprogesterone Acetate for Absence of Menstrual Periods in Woman Who Has Had Them
Provera completely jumpstarted my period after three months of no activity. I was on day 8 when it finally arrived, and have been very pleased with the results.
5Patient Review
4/28/2018
Medroxyprogesterone Acetate for Absence of Menstrual Periods in Woman Who Has Had Them
This drug was very effective in inducing a period. I took it for ten days and started my period around day seven or eight. It lasted for fourteen days. The second time I took this drug was for five days at 10mg to start a period and then take clomid. My period started three days after finishing the prescription. Besides mild cramping, I had no side effects, which is unusual for me when it comes to periods.
5Patient Review
3/15/2021
Medroxyprogesterone Acetate for Absence of Menstrual Periods in Woman Who Has Had Them
I'm on my second round of this medication. I have abnormal periods; I will ovulate but not shed the lining. Last year, when taking this medication, I did bleed heavily and have larger clots. But that was because I was getting rid of months of lining. I had mild cramping, which is normal for me. We are trying to conceive but no luck. Hoping this works as well as it did the first time.
3.7Patient Review
5/30/2019
Medroxyprogesterone Acetate for Absence of Menstrual Periods in Woman Who Has Had Them
I was prescribed this medication for heavy menstrual bleeding, and it definitely helped to lighten my flow and reduce the amount of blood clots. However, my period lasted longer than usual (nine days instead of the seven), which was a bit inconvenient.
View All Reviews
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about medroxyprogesterone acetate

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is medroxyprogesterone used for abortion?

"MPA was found to be not significantly different and is considered to be safe to use during pregnancy. It is unlikely to cause an abnormal fetus or lead to a miscarriage. Although this report does not address how effective MPA is, it seems to be a safe drug to use during pregnancy."

Answered by AI

What are the side effects of medroxyprogesterone acetate?

"If you experience any of the following side effects, tell your doctor or pharmacist: nausea, bloating, breast tenderness, headache, change in vaginal discharge, mood swings, blurred vision, dizziness, drowsiness, or weight gain/loss."

Answered by AI

Is medroxyprogesterone a steroid?

"Medroxyprogesterone is a synthetic progestin and oral contraceptive. It is structurally similar to the hormone progesterone and is used for a variety of purposes including contraception, menopausal hormone therapy, and treatment of endometriosis."

Answered by AI

Clinical Trials for Medroxyprogesterone Acetate

Have you considered Medroxyprogesterone Acetate clinical trials? We made a collection of clinical trials featuring Medroxyprogesterone Acetate, we think they might fit your search criteria.
Have you considered Medroxyprogesterone Acetate clinical trials? We made a collection of clinical trials featuring Medroxyprogesterone Acetate, we think they might fit your search criteria.
Have you considered Medroxyprogesterone Acetate clinical trials? We made a collection of clinical trials featuring Medroxyprogesterone Acetate, we think they might fit your search criteria.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top